Home › Companies › NEUROGENE INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and NEUROGENE INC.’s Form 8-K, filed June 12, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 12, 2025: 6 items on NEUROGENE INC.’s Form 8-K, filed June 12, 2025: 6 passed (calculated).
Significant dissent: 1 equity or compensation plan (26.0% against).
Notable dissent: 1 say-on-pay vote (70.9% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore NEUROGENE INC. in the interactive database Compare manager voting policies
These tallies are NEUROGENE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sarah B. Noonberg | 10,344,227 | -- | -- | 656,571 | 480,734 | 94% | Passed (calculated) | — |
| Elect Director: Robert "Keith" Woods | 10,444,580 | -- | -- | 556,218 | 480,734 | 95% | Passed (calculated) | — |
| 2. Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers | 7,721,866 | 3,174,484 | 104,448 | -- | 480,734 | 71% | Passed (calculated) | — |
| 3. Approval of an amendment to the Company's 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares issuable on exercise of prefunded warrants and | 8,067,746 | 2,829,550 | 103,502 | -- | 480,734 | 74% | Passed (calculated) | — |
| 4. Approval of an amendment to the Company's 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares issuable on exercise of prefunded warran | 10,794,908 | 101,329 | 104,561 | -- | 480,734 | 99.1% | Passed (calculated) | — |
| 5. Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 11,372,327 | 10,333 | 98,872 | -- | -- | 99.9% | Passed (calculated) | — |
Source: NEUROGENE INC., Form 8-K, filed with the SEC on June 12, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
106 asset managers disclosed a vote on at least one NEUROGENE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors for terms expiring in 2028: Robert Keith Woods
NEUROGENE INC.’s own tally for this item (“Elect Director: Robert "Keith" Woods”): 10,444,580 for, 556,218 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 629,332 for, 27,123 withheld, 138 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 405,116 | 0 | 0 | 0 | For |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| JPMorgan | 30,948 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 2,082 | 0 | 0 | 6,710 | Mixed |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 7,482 | Withhold |
| Global X | 6,847 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 4,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 4,159 | Withhold |
| Bridge Builder Trust | 3,588 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 2,046 | Withhold |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 1,650 | Withhold |
| Victory Capital | 0 | 0 | 0 | 1,475 | Withhold |
| DWS | 0 | 0 | 0 | 1,099 | Withhold |
| Calvert | 0 | 0 | 0 | 1,009 | Withhold |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 721 | Withhold |
| Nationwide | 504 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 396 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors for terms expiring in 2028: Sarah B. Noonberg
NEUROGENE INC.’s own tally for this item (“Elect Director: Sarah B. Noonberg”): 10,344,227 for, 656,571 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 186,618 for, 60,875 withheld, 409,100 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 405,116 | 0 | Abstain |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 0 | 0 | 0 | 51,987 | Withhold |
| JPMorgan | 30,948 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 6,710 | 0 | 0 | 2,082 | Mixed |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,482 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 4,572 | Withhold |
| ETFis Series Trust I | 4,159 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 3,588 | 0 | Abstain |
| Voya | 2,046 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 1,650 | 0 | 0 | 0 | For |
| Victory Capital | 1,475 | 0 | 0 | 0 | For |
| DWS | 1,099 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 1,009 | Withhold |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 721 | Withhold |
| Nationwide | 0 | 0 | 0 | 504 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 396 | 0 | Abstain |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to our 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock.
NEUROGENE INC.’s own tally for this item (“4. Approval of an amendment to the Company's 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares ”): 10,794,908 for, 101,329 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 130,204 for, 526,393 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 405,116 | 0 | 0 | Against |
| Fidelity | 66,566 | 20,408 | 0 | 0 | Mixed |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 30,948 | 0 | 0 | Against |
| Lincoln Financial | 9,100 | 6,668 | 0 | 0 | Mixed |
| Equitable | 0 | 8,792 | 0 | 0 | Against |
| Northern Trust | 0 | 8,788 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 7,482 | 0 | 0 | Against |
| Global X | 0 | 6,847 | 0 | 0 | Against |
| Charles Schwab | 0 | 5,790 | 0 | 0 | Against |
| Pacific Life | 0 | 4,572 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,159 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 3,588 | 0 | 0 | Against |
| Voya | 0 | 2,046 | 0 | 0 | Against |
| SEI | 0 | 1,700 | 0 | 0 | Against |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 0 | 1,650 | 0 | 0 | Against |
| Victory Capital | 0 | 1,475 | 0 | 0 | Against |
| DWS | 0 | 1,099 | 0 | 0 | Against |
| Calvert | 0 | 1,009 | 0 | 0 | Against |
| Franklin Templeton | 0 | 1,003 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 818 | 0 | 0 | Against |
| Dimensional | 0 | 721 | 0 | 0 | Against |
| Nationwide | 0 | 504 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 396 | 0 | 0 | Against |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to our 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock.
NEUROGENE INC.’s own tally for this item (“3. Approval of an amendment to the Company's 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares issuabl”): 8,067,746 for, 2,829,550 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 656,597 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 405,116 | 0 | 0 | Against |
| Fidelity | 0 | 86,974 | 0 | 0 | Against |
| Vanguard | 0 | 51,987 | 0 | 0 | Against |
| JPMorgan | 0 | 30,948 | 0 | 0 | Against |
| Lincoln Financial | 0 | 15,768 | 0 | 0 | Against |
| Equitable | 0 | 8,792 | 0 | 0 | Against |
| Northern Trust | 0 | 8,788 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 7,482 | 0 | 0 | Against |
| Global X | 0 | 6,847 | 0 | 0 | Against |
| Charles Schwab | 0 | 5,790 | 0 | 0 | Against |
| Pacific Life | 0 | 4,572 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,159 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 3,588 | 0 | 0 | Against |
| Voya | 0 | 2,046 | 0 | 0 | Against |
| SEI | 0 | 1,700 | 0 | 0 | Against |
| State Street | 0 | 1,658 | 0 | 0 | Against |
| ProShares | 0 | 1,650 | 0 | 0 | Against |
| Victory Capital | 0 | 1,475 | 0 | 0 | Against |
| DWS | 0 | 1,099 | 0 | 0 | Against |
| Calvert | 0 | 1,009 | 0 | 0 | Against |
| Franklin Templeton | 0 | 1,003 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 818 | 0 | 0 | Against |
| Dimensional | 0 | 721 | 0 | 0 | Against |
| Nationwide | 0 | 504 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 396 | 0 | 0 | Against |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
Prior year: 95.0% for (June 14, 2024 meeting) ▼ 24.1 pts
Description as filed by funds: To approve on an an (non-binding) basis the compensation of the Company's named executive officers.
NEUROGENE INC.’s own tally for this item (“2. Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers”): 7,721,866 for, 3,174,484 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 71% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 405,116 | 0 | 0 | 0 | For |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| JPMorgan | 30,948 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 8,792 | 0 | 0 | 0 | For |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,482 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 4,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,159 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,588 | 0 | 0 | 0 | For |
| Voya | 2,046 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 1,650 | 0 | 0 | 0 | For |
| Victory Capital | 1,475 | 0 | 0 | 0 | For |
| DWS | 1,099 | 0 | 0 | 0 | For |
| Calvert | 0 | 1,009 | 0 | 0 | Against |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 0 | 721 | 0 | 0 | Against |
| Nationwide | 504 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 396 | 0 | 0 | 0 | For |
Fund voting reports, all 34 managers: 654,863 for, 1,730 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 1,717,127 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,285,179 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 1,186,381 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,133,656 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 962,740 | 0 | 0 | 0 | For |
| Commodore Capital LP | 925,000 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 491,792 | 0 | 0 | 0 | For |
| Casdin Capital, LLC | 418,159 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 371,473 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 201,148 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 108,084 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 106,924 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 104,339 | 0 | 0 | 0 | For |
| State Street | 89,369 | 28 | 0 | 0 | For |
| Woodline Partners LP | 83,410 | 0 | 0 | 0 | For |
| BlackRock | 80,121 | 911 | 0 | 0 | For |
| JPMorgan | 76,112 | 0 | 0 | 0 | For |
| Fidelity | 75,622 | 0 | 0 | 0 | For |
| Northern Trust | 54,947 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 51,500 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 32,765 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 25,736 | 0 | 0 | 0 | For |
| Wellington | 25,043 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 24,261 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 22,862 | 0 | 0 | 0 | For |
Institutional-manager reports, all 85 managers: 9,754,589 for, 13,060 against. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify on an advisory (non-binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
NEUROGENE INC.’s own tally for this item (“5. Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 11,372,327 for, 10,333 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 656,593 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 405,116 | 0 | 0 | 0 | For |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| JPMorgan | 30,948 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 8,792 | 0 | 0 | 0 | For |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,482 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 4,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,159 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,588 | 0 | 0 | 0 | For |
| Voya | 2,046 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 1,650 | 0 | 0 | 0 | For |
| Victory Capital | 1,475 | 0 | 0 | 0 | For |
| DWS | 1,099 | 0 | 0 | 0 | For |
| Calvert | 1,009 | 0 | 0 | 0 | For |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 721 | 0 | 0 | 0 | For |
| Nationwide | 504 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 396 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 14,262,066 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.84% |
| 2 | Fidelity | 0.61% |
| 3 | Vanguard | 0.36% |
| 4 | JPMorgan | 0.22% |
| 5 | Lincoln Financial | 0.11% |
| 6 | Equitable | 0.06% |
| 7 | Northern Trust | 0.06% |
| 8 | AIG/SunAmerica | 0.05% |
| 9 | Global X | 0.05% |
| 10 | Charles Schwab | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Samsara BioCapital, LLC | 12.04% |
| 2 | Redmile Group, LLC | 9.01% |
| 3 | EcoR1 Capital, LLC | 8.32% |
| 4 | RTW INVESTMENTS, LP | 7.95% |
| 5 | BAKER BROS. ADVISORS LP | 6.75% |
| 6 | Commodore Capital LP | 6.49% |
| 7 | GREAT POINT PARTNERS LLC | 3.45% |
| 8 | Casdin Capital, LLC | 2.93% |
| 9 | ArrowMark Colorado Holdings LLC | 2.60% |
| 10 | Octagon Capital Advisors LP | 1.41% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Samsara BioCapital, L.P. | 1,731,671 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Redmile Group, LLC | 1,557,179 | — | Schedule 13G, filed February 17, 2026 |
| RTW Investments, LP | 1,498,829 | — | Schedule 13G, filed February 14, 2025 |
| Entities affiliated with EcoR1 Capital Fund, L.P. | 1,443,413 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| EcoR1 Capital, LLC | 1,442,902 | — | Schedule 13G, filed November 14, 2025 |
| Entities affiliated with Redmile Group, LLC | 1,438,033 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Entities affiliated with RTW Investments, LP | 1,434,645 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Rachel McMinn | 1,320,021 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Casdin Capital, LLC | 1,295,361 | — | Schedule 13G, filed February 14, 2025 |
| Entities affiliated with Casdin Capital, LLC | 1,295,361 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
Percentages above are of 14,262,066 shares outstanding, as reported by NEUROGENE INC. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At NEUROGENE INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 106 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 698 separate fund positions. On the most widely held item on that ballot — To approve on an an (non-binding) basis the compensation of the Company's named executive… — FOR was 71% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NEUROGENE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEUROGENE INC.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
NEUROGENE INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “NEUROGENE (NGNE) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/neurogene-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.